Ishares Trust · net assets $3.84B · 124 holdings as of June 30, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 98.7% · STIV: 1.3% · OTHER: 0.0% · DE: 0.0%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $80M | $0 | $131M |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $61.1M | $9.19M | $99.8M |
| Net realized gain (non-derivative) | $17.2M | $762K | $23.7M |
| Net unrealized appreciation (non-derivative) | $-48.1M | $53.6M | $150M |
The three months of the reporting period, as filed; month 3 ends June 30, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Eli Lilly And Company EC | $420M | 10.93% |
| Johnson & Johnson EC | $271M | 7.04% |
| Abbvie Inc. EC | $197M | 5.12% |
| Unitedhealth Group Incorporated EC | $169M | 4.40% |
| Merck & Co., Inc. EC | $158M | 4.12% |
| Astrazeneca PLC EC | $145M | 3.76% |
| Roche Holding Ag EC | $144M | 3.75% |
| Novartis Ag EC | $143M | 3.71% |
| Amgen Inc. EC | $97.5M | 2.54% |
| Thermo Fisher Scientific Incorporated EC | $93M | 2.42% |
| Abbott Laboratories EC | $78.9M | 2.05% |
| Gilead Sciences, Inc. EC | $78.3M | 2.04% |
| Novo Nordisk A/s EC | $76.4M | 1.99% |
| Intuitive Surgical, Inc. EC | $70.3M | 1.83% |
| Pfizer Inc. EC | $68.5M | 1.78% |
| Cvs Health Corporation EC | $65.9M | 1.71% |
| Vertex Pharmaceuticals Incorporated EC | $62.9M | 1.64% |
| Danaher Corporation EC | $59.9M | 1.56% |
| Bristol-myers Squibb Company EC | $58.7M | 1.53% |
| Stryker Corporation EC | $54.2M | 1.41% |
| Gsk PLC EC | $53.1M | 1.38% |
| Medtronic Public Limited Company EC | $50.1M | 1.30% |
| Sanofi Sa EC | $45.5M | 1.18% |
| Mckesson Corporation EC | $45.3M | 1.18% |
| Elevance Health, Inc. EC | $41.9M | 1.09% |
| Blackrock Funds Iii: Blackrock Cash Funds: Institutional; Sl Agency Shares STIV | $40.6M | 1.06% |
| The Cigna Group EC | $36.4M | 0.95% |
| Boston Scientific Corporation EC | $31.7M | 0.82% |
| Regeneron Pharmaceuticals, Inc. EC | $31.1M | 0.81% |
| Hca Healthcare, Inc. EC | $30.2M | 0.79% |
| Argenx Se EC | $28.6M | 0.74% |
| Cardinal Health, Inc. EC | $27.8M | 0.72% |
| Cencora, Inc. EC | $27.5M | 0.71% |
| Essilorluxottica Sa EC | $27.4M | 0.71% |
| Bayer Aktiengesellschaft EC | $27.1M | 0.71% |
| Hoya Corporation EC | $26.9M | 0.70% |
| Edwards Lifesciences Corporation EC | $26M | 0.68% |
| Takeda Pharmaceutical Company Limited EC | $25.3M | 0.66% |
| Humana Inc. EC | $23.8M | 0.62% |
| Lonza Group Ag EC | $23.6M | 0.61% |
| Galderma Group Ag EC | $20.8M | 0.54% |
| Idexx Laboratories, Inc. EC | $20.7M | 0.54% |
| Becton, Dickinson And Company EC | $20.7M | 0.54% |
| Haleon PLC EC | $20.4M | 0.53% |
| Sandoz Group Ag EC | $19.8M | 0.52% |
| Csl Limited EC | $19.3M | 0.50% |
| Agilent Technologies, Inc. EC | $18.7M | 0.49% |
| Waters Corporation EC | $18.4M | 0.48% |
| Ucb Sa EC | $18M | 0.47% |
| Otsuka Holdings Co., Ltd. EC | $17.1M | 0.44% |
| Alcon Ag EC | $16.8M | 0.44% |
| Iqvia Holdings Inc EC | $16.1M | 0.42% |
| Biogen Inc. EC | $15.9M | 0.41% |
| Daiichi Sankyo Company, Limited EC | $15.2M | 0.40% |
| Zoetis Inc. EC | $15M | 0.39% |
| Centene Corporation EC | $15M | 0.39% |
| Chugai Pharmaceutical Co., Ltd. EC | $14.7M | 0.38% |
| Ge Healthcare Technologies Inc. EC | $14.5M | 0.38% |
| Resmed Inc. EC | $14.1M | 0.37% |
| Veeva Systems Inc. EC | $13.3M | 0.35% |
Showing top 60 of 124 holdings.
Loading...